Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer

NDAQ:APHA - Post by User

Aphria Inc.

Bullboard Posts

Comment by GoBlue2016on Dec 10, 2017 8:45pm

186 Views

Post# 27127971

RE:RE:Heads up!! Senate IFFY

Delays may soften sector SP including Aph... but Aph and it’s positive EBITDA would cruise through a delay. The amount of pain most other LPs would face would be crippling for many.

Funded capacity is soooo important.

GoBlue

ProfCornelius wrote: APH would be just fine but a delay of any extended period could crush LP's, that burn copious amounts of cash as they are relying on the July 1/18 hard date for REC.
Blue mentioned distressed assets ealier. APH could gobble up multiple LP's if there was a delay!

kittykarma wrote:
https://www.theglobeandmail.com/news/politics/legal-marijuana-deadline-may-be-up-in-smoke-as-tory-senators-stall-bills/article37284998/